CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Veratraldehyde 5g  | ≥99%

CSNpharm

Veratraldehyde, a natural product isolated and purified from the herbs of Cymbopogon javanensis, can be reduced by aryl-alcohol dehydrogenase to their corresponding alcohols, which was oxidized by aryl-alcohol oxidase, producing H2O2.

More Information Supplier Page

Veratramine 10mg  | ≥99%

CSNpharm

Veratramine is a natually occuring alkaloid isolated from the rhizomes of Veratrum and can inhibit the Hh signaling-dependent proliferation of NIH/3T3 cells for it is an analog of cyclopamine.

More Information Supplier Page

Veratramine 5mg  | ≥99%

CSNpharm

Veratramine is a natually occuring alkaloid isolated from the rhizomes of Veratrum and can inhibit the Hh signaling-dependent proliferation of NIH/3T3 cells for it is an analog of cyclopamine.

More Information Supplier Page

Veratramine 100mg  | ≥99%

CSNpharm

Veratramine is a natually occuring alkaloid isolated from the rhizomes of Veratrum and can inhibit the Hh signaling-dependent proliferation of NIH/3T3 cells for it is an analog of cyclopamine.

More Information Supplier Page

Veratramine 50mg  | ≥99%

CSNpharm

Veratramine is a natually occuring alkaloid isolated from the rhizomes of Veratrum and can inhibit the Hh signaling-dependent proliferation of NIH/3T3 cells for it is an analog of cyclopamine.

More Information Supplier Page

Verteporfin 50mg  | ≥98%

CSNpharm

Verteporfin, a benzoporphyrin derivative monoacid ring A, inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent.

More Information Supplier Page

Verteporfin 10mg  | ≥98%

CSNpharm

Verteporfin, a benzoporphyrin derivative monoacid ring A, inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent.

More Information Supplier Page

Verteporfin 25mg  | ≥98%

CSNpharm

Verteporfin, a benzoporphyrin derivative monoacid ring A, inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent.

More Information Supplier Page

Verteporfin 100mg  | ≥98%

CSNpharm

Verteporfin, a benzoporphyrin derivative monoacid ring A, inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent.

More Information Supplier Page

Verteporfin 5mg  | ≥98%

CSNpharm

Verteporfin, a benzoporphyrin derivative monoacid ring A, inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent.

More Information Supplier Page

Verteporfin 1mg  | ≥98%

CSNpharm

Verteporfin, a benzoporphyrin derivative monoacid ring A, inhibits TEAD–YAP association and YAP-induced liver overgrowth. It is also a potent second-generation photosensitizing agent.

More Information Supplier Page

VGX-1027 10mg  | ≥99%

CSNpharm

VGX-1027 is an orally active immunomodulatory agent that primarily targets macrophages, it can inhibit TNF-α secretion via interference of macrophage toll-like receptor (TLR) 4 and TLR 2/6 signaling pathway. VGX-1027 also reduces the secretion of pro-inflammatory cytokines IL1-β, IL-10 and IFN-γ.

More Information Supplier Page

VGX-1027 25mg  | ≥99%

CSNpharm

VGX-1027 is an orally active immunomodulatory agent that primarily targets macrophages, it can inhibit TNF-α secretion via interference of macrophage toll-like receptor (TLR) 4 and TLR 2/6 signaling pathway. VGX-1027 also reduces the secretion of pro-inflammatory cytokines IL1-β, IL-10 and IFN-γ.

More Information Supplier Page

VGX-1027 50mg  | ≥99%

CSNpharm

VGX-1027 is an orally active immunomodulatory agent that primarily targets macrophages, it can inhibit TNF-α secretion via interference of macrophage toll-like receptor (TLR) 4 and TLR 2/6 signaling pathway. VGX-1027 also reduces the secretion of pro-inflammatory cytokines IL1-β, IL-10 and IFN-γ.

More Information Supplier Page

Vidarabine 100mg  | ≥99%

CSNpharm

Vidarabine is an antiviral drug effects by interfering with the synthesis of viral DNA, which is used in treatment of herpes simplex and varicella zoster viruses.

More Information Supplier Page

Vidarabine 250mg  | ≥99%

CSNpharm

Vidarabine is an antiviral drug effects by interfering with the synthesis of viral DNA, which is used in treatment of herpes simplex and varicella zoster viruses.

More Information Supplier Page

Vigabatrin 100mg  | ≥98%

CSNpharm

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transaminase.

More Information Supplier Page

Vigabatrin 10mg  | ≥98%

CSNpharm

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transaminase.

More Information Supplier Page

Vigabatrin 25mg  | ≥98%

CSNpharm

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transaminase.

More Information Supplier Page

Vigabatrin 5mg  | ≥98%

CSNpharm

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transaminase.

More Information Supplier Page

Vigabatrin 50mg  | ≥98%

CSNpharm

Vigabatrin is a structural analog of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) that irreversibly inhibits the catabolism of GABA by GABA transaminase.

More Information Supplier Page

Vilazodone 10mg  | ≥99%

CSNpharm

Vilazodone is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.

More Information Supplier Page

Vilazodone 1mg  | ≥99%

CSNpharm

Vilazodone is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.

More Information Supplier Page

Vilazodone 50mg  | ≥99%

CSNpharm

Vilazodone is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.

More Information Supplier Page

Vilazodone 5mg  | ≥99%

CSNpharm

Vilazodone is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression.

More Information Supplier Page